Generic Metadate ER

Generic Metadate ER: An Overview

Metadate ER^® (methylphenidate extended-release) is a prescription medication that has been licensed to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.

 

The drug was first manufactured by UCB, Inc. However, the patent has since expired, which means that generic Metadate ER is now available as well.

 

Strengths of Generic Metadate ER

Generic Metadate ER is sold under the name Methylphenidate Extended-Release tablets, which come in the following strengths:

 

Who Makes Generic Metadate ER?

Generic Metadate ER is made by several manufacturers, including:

 

Is Generic Methylphenidate Extended-Release as Good as Metadate ER?

All generic medications must have certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generic versions are equivalent to the brand-name medications and assigns a rating to each one. An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic Metadate ER versions that are currently available have an "AB" rating, meaning they should be equivalent to brand-name Metadate ER.

 

However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers or dyes or other ingredients, which may cause problems for people with certain allergies or sensitivities.